-
Non Regulatory December 23, 2022 EnglishInitiator Pharma has decided not to exercise the option for an undisclosed pain asset
-
Regulatory December 23, 2022 EnglishInitiator Pharma: Financial calendar for 2023
Share
Initiator Pharma Numbers
-
Expected Number of men affected by Erectile Dysfunction worldwide by 2025 322 million
-
Number of people worldwide that are diagnosed with Trigeminal Neuralgia every year: 15000
-
Men with Erectile Dysfunction who do not respond to drug therapy 40 %

Initiator Pharma currently has a portfolio of four projects, of which two are in clinical development and two are in preclinical development.

CEO letter
Thanks to a successful capitalization of the company via directed share issues and a fully guaranteed rights issue at the end of June, we entered the third quarter with secured financing well into 2024 allowing us to continue the advancement of all our clinical programs according to our overall plans and priorities.
